<bill session="116" type="h" number="6670" updated="2023-01-11T13:43:02Z">
  <state datetime="2020-05-01">REFERRED</state>
  <status>
    <introduced datetime="2020-05-01"/>
  </status>
  <introduced datetime="2020-05-01"/>
  <titles>
    <title type="display">Prescription for American Drug Independence Act of 2020</title>
    <title type="official" as="introduced">To provide for an exploration of strategies to increase domestic manufacturing and diversify the supply chain of critical drugs, and for other purposes.</title>
    <title type="short" as="introduced">Prescription for American Drug Independence Act of 2020</title>
  </titles>
  <sponsor bioguide_id="E000215"/>
  <cosponsors>
    <cosponsor bioguide_id="B001284" joined="2020-05-01"/>
    <cosponsor bioguide_id="C001090" joined="2020-07-09"/>
    <cosponsor bioguide_id="H001056" joined="2020-06-29"/>
    <cosponsor bioguide_id="H001083" joined="2020-06-18"/>
    <cosponsor bioguide_id="L000566" joined="2020-06-08"/>
    <cosponsor bioguide_id="P000599" joined="2020-05-12"/>
    <cosponsor bioguide_id="R000577" joined="2020-05-12"/>
  </cosponsors>
  <actions>
    <action datetime="2020-05-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-05-01" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="6800" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government studies and investigations"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2020-05-12T21:03:35Z" status="Introduced in House">Prescription for American Drug Independence Act of 2020

This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) establish a committee of experts on drug-supply issues, (2) convene a symposium to recommend strategies for ending&#160;U.S. dependence on foreign manufacturing of critical drugs, and (3) report on the symposium's proceedings.</summary>
</bill>
